Ziopharm says lymphoma drug may get EU incentives - Bloomberg
Ziopharm says lymphoma drug may get EU incentivesBloombergBy AP NEW YORK (AP) %26mdash; Drugmaker Ziopharm Oncology Inc. said Thursday its lymphoma drug candidate Zinapar was recommended for orphan drug incentives in the ...ZIOPHARM Gets Positive Opinion For Orphan Drug Designation For DarinaparsinRTT NewsZiopharm cancer drug gets EU orphan drug recommendationReutersZIOPHARM Receives Positive Opinion for Orphan Drug Designation for ...Business Wire (press release)BusinessWeekall 25 news articles��
Blog Content
Post a Comment